Comprehensive study of the antidiabetic drug metformin and its transformation product guanylurea in Greek wastewaters

Water Research

Volumn 70, Issue , 2015, Pages 436-448

  Kosma, Christina I ^a   Lambropoulou, Dimitra A ^b   Albanis, Triantafyllos A ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Guanylurea; Metformin; Occurrence; Removals; Risk assessment; Wastewaters

Indexed keywords

ACTIVATED SLUDGE PROCESS; ANIONIC SURFACTANTS; BIOLOGICAL WATER TREATMENT; RECLAMATION; RISK ASSESSMENT; SEWAGE PUMPING PLANTS; SURFACE WATERS; TOXICITY; WASTEWATER TREATMENT; WATER POLLUTION; WATER TREATMENT PLANTS;

ANALYTICAL METHOD; ANTIDIABETIC DRUG; BIOLOGICAL TRANSFORMATION; CONVENTIONAL ACTIVATED SLUDGE TREATMENTS; GUANYLUREA; METFORMINS; OCCURRENCE; RISKS ASSESSMENTS; TRANSFORMATION PRODUCTS; WASTE WATER TREATMENT PLANTS;

EFFLUENTS;

ANIONIC SURFACTANT; METFORMIN; ANTIDIABETIC AGENT; GUANIDINE DERIVATIVE; N-GUANYLUREA; UREA; WASTE WATER; WATER POLLUTANT;

ACTIVATED SLUDGE; AQUATIC ENVIRONMENT; CONCENTRATION (COMPOSITION); DRUG; SEASONAL VARIATION; SURFACTANT; WASTEWATER;

ACTIVATED SLUDGE; ANALYTIC METHOD; AQUATIC ENVIRONMENT; ARTICLE; BIOTRANSFORMATION; ENVIRONMENTAL IMPACT; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHYSICAL CHEMISTRY; RISK ASSESSMENT; VALIDATION STUDY; WASTE WATER; WASTE WATER MANAGEMENT; WATER SUPPLY; ANALOGS AND DERIVATIVES; ANALYSIS; ENVIRONMENTAL MONITORING; GREECE; SEWAGE; TOXICITY; WATER POLLUTANT;

GREECE;

ENVIRONMENTAL MONITORING; GREECE; GUANIDINES; HYPOGLYCEMIC AGENTS; METFORMIN; RISK ASSESSMENT; UREA; WASTE DISPOSAL, FLUID; WASTE WATER; WATER POLLUTANTS, CHEMICAL;

EID: 84920163729     PISSN: 00431354     EISSN: 18792448     Source Type: Journal    
DOI: 10.1016/j.watres.2014.12.010     Document Type: Article

References (44)

1. AbuRuz S., Millership J., McElnay J. The development and validation of liquid chromatography method for the simultaneous determination of metformin and glipizide, gliclazide, glibenclamide or glimperide in plasma. J. Chromatogr. B: Anal. Technol. Biomed. Life Sci. 2005, 817(2):277-286.
2. Al-Odaini N.A., Zakaria M.P., Yaziz M.I., Surif S. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry. J. Chromatogr. A 2010, 1217(44):6791-6806.
3. Al-Qaim F.F., Abdullah M.P., Othman M.R., Latip J., Zakaria Z. Multi-residue analytical methodology-based liquid chromatography-time-of-flight-mass spectrometry for the analysis of pharmaceutical residues in surface water and effluents from sewage treatment plants and hospitals. J. Chromatogr. A 2014, 1345:139-153.
4. Blair B.D., Crago J.P., Hedman C.J., Klaper R.D. Pharmaceuticals and personal care products found in the Great Lakes above concentrations of environmental concern. Chemosphere 2013, 93(9):2116-2123.
5. Blair B.D., Crago J.P., Hedman C.J., Treguer R.J.F., Magruder C., Royer L.S., Klaper R.D. Evaluation of a model for the removal of pharmaceuticals, personal care products, and hormones from wastewater. Sci. Total Environ. 2013, 444:515-521.
6. Carlsson C., Johansson A.K., Alvan G., Bergman K., Kühler T. Are pharmaceuticals potent environmental pollutants?. Part II: environmental risk assessments of selected pharmaceutical excipients. Sci. Total Environ. 2006, 364(1-3):88-95.
7. Carmona E., Andreu V., Picó Y. Occurrence of acidic pharmaceuticals and personal care products in Turia River Basin: from waste to drinking water. Sci. Total Environ. 2014, 484(1):53-63.
8. Cahill J.D., Furlong E.T., Burkhardt M.R., Kolpin D., Anderson L.G. Determination of pharmaceutical compounds in surface- and ground-water samples by solid-phase extraction and high-performance liquid chromatographyβ€″electrospray ionization mass spectrometry. J. Chromatogr. A 2004, 1041(1-2):171-180.
9. Collin F., Khoury H., Bonnefont-Rousselot D., Thérond P., Legrand A., Jore D., Gardès-Albert M. Liquid chromatographic/electrospray ionization mass spectrometric identification of the oxidation end-products of metformin in aqueous solutions. J. Mass Spectrom. 2004, 39(8):890-902.
10. Dong Z., Senn D.B., Moran R.E., Shine J.P. Prioritizing environmental risk of prescription pharmaceuticals. Regul. Toxicol. Pharmacol. 2013, 65(1):60-67.
11. Donia A.M., Awad M.K. Thermal stabilities, electronic properties and structures of metformin-metal complexes - molecular orbital investigation. J. Therm. Analysis 1995, 44(6):1493-1498.
12. Eggen T., Lillo C. Antidiabetic II drug metformin in plants: uptake and translocation to edible parts of cereals, oily seeds, beans, tomato, squash, carrots, and potatoes. J. Agric. Food Chem. 2012, 60(28):6929-6935.
13. Escher B.I., Baumgartner R., Koller M., Treyer K., Lienert J., Mcardell C.S. Environmental toxicology and risk assessment of pharmaceuticals from hospital wastewater. Water Res. 2011, 45(1):75-92.
14. Gartiser S., Hafner C., Kronenberger-Schäfer K., Happel O., Trautwein C., Kümmerer K. Approach for detecting mutagenicity of biodegraded and ozonated pharmaceuticals, metabolites and transformation products from a drinking water perspective. Environ. Sci. Pollut. Res. 2012, 19(8):3597-3609.
15. Gaurav, Malik A.K., Rai P.K. Solid phase microextraction-high performance liquid chromatographic determination of octahydro-1,3,5,7-tetranitro-1,3,5,7-tetrazocine (HMX) and Hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX) in the presence of sodium dodecyl sulfate surfactant. J. Sep. Sci. 2008, 31(12):2173-2181.
16. Gros M., Petrović M., Ginebreda A., Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ. Int. 2010, 36(1):15-26.
17. Gros M., Rodríguez-Mozaz S., Barceló D. Rapid analysis of multiclass antibiotic residues and some of their metabolites in hospital, urban wastewater and river water by ultra-high-performance liquid chromatography coupled to quadrupole-linear ion trap tandem mass spectrometry. J. Chromatogr. A 2013, 1292:173-188.
18. Hanisch B., Abbas B., Kratz W., Schüürmann G. Human drugs in aquatic ecosystems: approach for the environmental risk assessment of drug residues. Umweltwissenschaften Schadst. 2004, 16(4):223-238.
19. Keal J., Somogyi A. Rapid and sensitive high-performance liquid chromatographic assay for metformin in plasma and urine using ion-pair extraction techniques. J. Chromatogr. - Biomed. Appl. 1986, 378(2):503-508.
20. Kolpin D.W., Furlong E.T., Meyer M.T., Thurman E.M., Zaugg S.D., Barber L.B., Buxton H.T. Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Environ. Sci. Technol. 2002, 36(6):1202-1211.
21. Kosma C.I., Lambropoulou D.A., Albanis T.A. Occurrence and removal of PPCPs in municipal and hospital wastewaters in Greece. J. Hazard. Mater. 2010, 179(1-3):804-817.
22. Kosma C.I., Lambropoulou D.A., Albanis T.A. Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. Sci. Total Environ. 2014, 466-467:421-438.
23. Martín J., Buchberger W., Santos J.L., Alonso E., Aparicio I. High-performance liquid chromatography quadrupole time-of-flight mass spectrometry method for the analysis of antidiabetic drugs in aqueous environmental samples. J. Chromatogr. B 2012, 895-896(0):94-101.
24. Montforts H.M.M.M. The Trigger Values in the Environmental Risk Assessment for (Veterinary) Medicines in the European Union: a Critical Appraisal 2005, RIVM report 601500002/2005 BA Bilthoven, The Netherlands.
25. Oosterhuis M., Sacher F., ter Laak T.L. Prediction of concentration levels of metformin and other high consumption pharmaceuticals in wastewater and regional surface water based on sales data. Sci. Total Environ. 2013, 442:380-388.
26. Ottmar K.J., Colosi L.M., Smith J.A. Development and application of a model to estimate wastewater treatment plant prescription pharmaceutical influent loadings and concentrations. Bull. Environ. Contam. Toxicol. 2010, 84(5):507-512.
27. Padhye L.P., Yao H., Kung'u F.T., Huang C.H. Year-long evaluation on the occurrence and fate of pharmaceuticals, personal care products, andendocrine disrupting chemicals in an urban drinking water treatment plant. Water Res. 2014, 51:266-276.
28. Rosi-Marshall E.J., Kincaid D.W., Bechtold H.A., Royer T.V., Rojas M., Kelly J.J. Pharmaceuticals suppress algal growth and microbial respiration and alter bacterial communities in stream biofilms. Ecol. Appl. 2013, 23(3):583-593.
29. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol. Lett. 2003, 144(3):383-395.
30. Sanderson H., Thomsen M. Comparative analysis of pharmaceuticals versus industrial chemicals acute aquatic toxicity classification according to the United Nations classification system for chemicals. Assessment of the (Q)SAR predictability of pharmaceuticals acute aquatic toxicity and their predominant acute toxic mode-of-action. Toxicol. Lett. 2009, 187(2):84-93.
31. Santos L.H.M.L.M., Gros M., Rodriguez-Mozaz S., Delerue-Matos C., Pena A., Barceló D., Montenegro M.C.B.S.M. Contribution of hospital effluents to the load of pharmaceuticals in urban wastewaters: Identification of ecologically relevant pharmaceuticals. Sci. Total Environ. 2013, 461-462:302-316.
32. Scheurer M., Michel A., Brauch H.J., Ruck W., Sacher F. Occurrence and fate of the antidiabetic drug metformin and its metabolite guanylurea in the environment and during drinking water treatment. Water Res. 2012, 46(15):4790-4802.
33. Scheurer M., Sacher F., Brauch H.J. Occurrence of the antidiabetic drug metformin in sewage and surface waters in Germany. J. Environ. Monit. 2009, 11(9):1608-1613.
34. Shraim A., Diab A., Alsuhaimi A., Niazy E., Metwally M., Amad M., Sioud S., Dawoud A. Analysis of some pharmaceuticals in municipal wastewater of Almadinah Almunawarah. Arabian J. Chem. 2012, 10.1016/j.arabjc.2012.11.014.
35. Stamatis N., Triantafyllidis V., Hela D., Konstantinou I. Occurrence and distribution of selected pharmaceutical compounds on sewage-impacted section of River Acheloos, Western Greece. Int. J. Environ. Anal. Chem. 2013, 93(15):1602-1619.
36. Stamatis N.K., Konstantinou I.K. Occurrence and removal of emerging pharmaceutical, personal care compounds and caffeine tracer in municipal sewage treatment plant in Western Greece. J. Environ. Sci. Health - Part B Pesticides, Food Contam. Agric. Wastes 2013, 48(9):800-813.
37. ter Laak T., Baken K. The Occurrence, Fate and Ecological and Human Health Risks of Metformin and Guanylurea in the Water Cycle - a Literature Review 2014, KWR, Watercycle Research Institute Nieuwegein, The Netherlands.
38. Thomas K., Reid M., Langford K. Methodology for the Analysis of Selected Pharmaceuticals and Drugs of Abuse in Sediments and Sludge 2010, SNIFFER, Scottish Environment Protection Agency (SEPA), Northern Ireland Environment Agency (NIEA), and the Environment Agency (EA).
39. Trautwein C., Kümmerer K. Incomplete aerobic degradation of the antidiabetic drug Metformin and identification of the bacterial dead-end transformation product Guanylurea. Chemosphere 2011, 85(5):765-773.
40. Valcárcel Y., González Alonso S., Rodríguez-Gil J.L., Gil A., Catalá M. Detection of pharmaceutically active compounds in the rivers and tap water of the Madrid Region (Spain) and potential ecotoxicological risk. Chemosphere 2011, 84(10):1336-1348.
41. Van Nuijs A.L.N., Tarcomnicu I., Simons W., Bervoets L., Blust R., Jorens P.G., Neels H., Covaci A. Optimization and validation of a hydrophilic interaction liquid chromatography-tandem mass spectrometry method for the determination of 13 top-prescribed pharmaceuticals in influent wastewater. Anal. Bioanal. Chem. 2010, 398(5):2211-2222.
42. Verlicchi P., Al Aukidy M., Zambello E. Occurrence of pharmaceutical compounds in urban wastewater: removal, mass load and environmental risk after a secondary treatment - a review. Sci. Total Environ. 2012, 429:123-155.
43. Vulliet E., Cren-Olivé C. Screening of pharmaceuticals and hormones at the regional scale, in surface and groundwaters intended to human consumption. Environ. Pollut. 2011, 159(10):2929-2934.
44. Zhao J.L., Ying G.G., Liu Y.S., Chen F., Yang J.F., Wang L., Yang X.B., Stauber J.L., Warne M.S.J. Occurrence and a screening-level risk assessment of human pharmaceuticals in the pearl river system, South China. Environ. Toxicol. Chem. 2010, 29(6):1377-1384.